CD8A and cancer: And when it comes to the MHC protein complex binding/receptor activity, they are in charge of binding peptides derived from a cell’s expressed genes, then transporting, and displaying this antigenic information on the cell surface, so that CD8 T cells can recognize pathological cells that are synthesizing abnormal proteins, such as cancers that are expressing mutated proteins (41).